Clinical Trial Update: A Study of LY2334737 in Participants With Cancer That is Advanced and/or Has Spread [Phase 1]

View source ↗

Summary

Phase 1 trial update for LY2334737 in advanced/metastatic cancer; results posted after completion.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Malignant Solid Tumor
• Solid Tumor
• Tumor

Drugs mentioned

• LY2334737

Snippet

Sponsor: Eli Lilly and Company | Conditions: Malignant Solid Tumor, Solid Tumor | Phase 1 | Status: COMPLETED | Results posted: 2019-06-17